Coleman, C N <br/><br/>
Enhancement of the clinical activity of melphalan by the hypoxic cell sensitizer misonidazole.  [electronic resource] 

 -  Cancer research  Jun 1988 
 - 3528-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Drug Evaluation<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Misonidazole--administration & dosage